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BASIC SCIENCE ARTICLE
Changes in arginase isoforms in a murine model of neonatal
brain hypoxia–ischemia
Jana K. Mike1, Praneeti Pathipati1, R. Ann Sheldon2 and Donna M. Ferriero1,2
BACKGROUND: Arginases (ARG isoforms, ARG-1/ARG-2) are key regulatory enzymes of inflammation and tissue repair; however,
their role after neonatal brain hypoxia (H) and hypoxia–ischemia (HI) remains unknown.
METHODS: C57BL/6 mice subjected to the Vannucci procedure on postnatal day (P9) were sacrificed at different timepoints. The
degree of brain damage was assessed histologically. ARG spatiotemporal localization was determined via immunohistochemistry.
ARG expression was measured by Western blot and activity spectrophotometrically.
RESULTS: ARG isoform expression increased during neurodevelopment (P9–P17) in the cortex and hippocampus. This was
suppressed with H and HI only in the hippocampus. In the cortex, both isoforms increased with H alone and only ARG-2 increased
with HI at 3 days. ARG activity during neurodevelopment remained unchanged, but increased at 1 day with H and not HI. ARG-1
localized with microglia at the injury site as early as 4 h after injury, while ARG-2 localized with neurons.
CONCLUSIONS: ARG isoform expression increases with age from P9 to P17, but is suppressed by injury specifically in the
hippocampus and not in the cortex. Both levels and activity of ARG isoforms increase with H, while ARG-1 immunolabelling is
upregulated in the HI cortex. Evidently, ARG isoforms in the brain differ in spatiotemporal localization, expression, and activity
during neurodevelopment and after injury.
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IMPACT:
● Arginase isoforms change during neurodevelopment and after neonatal brain HI.
● This is the first study investigating the key enzymes of inflammation and tissue repair called arginases following murine
neonatal brain HI.
● The highly region- and cell-specific expression suggests the possibility of specific functions of arginases.
● ARG-1 in microglia at the injury site may regulate neuroinflammation, while ARG-2 in neurons of developmental structures may
impact neurodevelopment.
● While further studies are needed to describe the exact role of ARGs after neonatal brain HI, our study adds valuable data on
anatomical localization and expression of ARGs in brain during development and after stroke.
INTRODUCTION
A critical determinant of neuronal survival after brain
hypoxia–ischemia (HI) is neuroinflammation, resulting from
mechanisms of oxidant stress, inflammation, and excitotoxicity.
The neonatal brain has a low antioxidant reserve; therefore,
oxidative stress such as that from excess nitric oxide (NO) may
lead to neuroinflammation, neuronal death, and poor clinical
outcomes.1
The key regulatory enzymes of inflammation and tissue repair
are arginases (ARGs), which are expressed in two isoforms: ARG-1
predominantly found in the liver and lung, and the more recently
discovered ARG-2, confined mainly to the kidney, brain, prostate,
and pancreas.2 ARGs are generally described as urea cycle
enzymes, and recent findings suggest that the complete urea
cycle could also occur in the brain3 and play a role in disease.4–6
As ARG regulate NO synthesis via competition for the common
substrate arginine7 (NO pathway), they are capable of regulating
the acute phase of inflammation through processes such as
oxidative stress,8 apoptosis,9 or microglia polarization.10 Addition-
ally, certain products of the ARG metabolic pathways (such as
polyamines via a polyamine pathway) are essential for cell
proliferation and collagen formation,11 with predicted roles in
neuronal growth,12 axonal regeneration,13 and glial scar forma-
tion.14 Consequently, ARG clearly impact neurodevelopment as
well as processes after brain injury.15 The ability to regulate NO
and polyamine synthesis gives the ARG pathway the potential to
serve in new therapies of brain injury, and recent findings in this
field have reflected this. The number of studies describing a new
role for ARG in various conditions is growing, and a role for ARG
has already been recognized in adult brain pathologies, such as
inflammation after traumatic brain injury4 and autoimmune
encephalitis.5 Recently, increased ARG-1 was reported in the
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blood of stroke patients with levels correlating with infarct size,6
suggesting the involvement of ARG in post-hypoxic–ischemic
mechanisms. So far, many studies suggest ARG-1 as being mostly
associated with the role of a marker of “pro-repair” microglia, and
ARG-2 mostly in regulation of cerebral blood flow.15 However, the
exact role of ARG remains unclear. While changes in ARG
expression and activity have been described in embryonal and
adult ages,16–18 to our knowledge there are very few studies
focused on ARG expression and activity during the most robust
period of brain development in the postnatal age15–23 and none
after HI injury. Here, we describe for the first time the isoform-
specific ARG expression during the postnatal period as a factor in
development as well as after HI.
MATERIALS AND METHODS
Animals
All animal research was approved by the University of California
San Francisco Institutional Animal Care and Use Committee and
was performed in accordance with the Guide for the Care and Use
of Laboratory Animals. Wild-type mice of the C57BL/6 strain (The
Jackson Laboratory, Sacramento, CA) of both sexes were used for
all experiments.
Induction of HI
Neonatal HI was induced in postnatal day9 (P9) mice using the
Vannucci procedure. Briefly, unilateral ischemic injury was induced
by coagulation of the left common carotid artery under isoflurane
anesthesia (4% isoflurane, balance oxygen). The pups were
recovered for 1 h with their dam. Global hypoxic injury was
triggered by exposure to 50 min of hypoxia in a humidified
chamber at 37 °C with 10% oxygen/balance nitrogen. The mice
were euthanized at 1 h, 4 h, 12 h, 1 day, 3 days, 5 days, and 8 days
after the procedure. Naive and sham mice (N) were used as
controls. The contralateral hypoxic hemisphere (H) in injured
animals was studied separately as it was exposed to global
hypoxia during the Vannucci procedure and hypoxia alone has
been shown to be a stimulus for ARG expression.16 The
hypoxic–ischemic hemisphere was exposed to the initial ischemic
insult and subsequent global hypoxia.
Histology and immunohistochemistry
At each specific timepoint, mice were flushed with 8 mL of
phosphate-buffered saline (PBS) and perfused with 10 mL of 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Brains were
post fixed in 4% paraformaldehyde overnight and transferred to
30% sucrose till they sank (3 days). Brains were then flash frozen in
2-methyl butane on dry ice and stored at −80 °C. Coronal sections
were cut on a cryostat (12-μm-thick serial sections, 120 μm apart).
Brain injury was determined in eight coronal sections stained with
Cresyl violet using histopathological scoring in a blinded manner.
Sections were assessed rostral to caudal. Regions scored included
the following: anterior cortex; middle cortex; posterior cortex;
anterior, middle, and posterior caudate/striatum; thalamus;
hippocampus CA1, CA2, and CA3; and the dentate gyrus. Scores
were assigned for each region as follows: 0= no injury, 1=
minimal cell loss manifested by scattered shrunken neurons and
glia, 2=moderate cell loss with infarction in a columnar
distribution in the cortex with concomitant gliosis or the shrunken
hippocampus with cell loss throughout the Sommer’s sector, and
3= severe cell loss and gliosis with cystic infarction, for a total
score of 0–33.
Double immunofluorescence labeling was performed on brain
sections that were defrosted and air dried at room temperature (RT)
for 1 h. Following antigen retrieval in 10mM citrate buffer (pH 6.0)
for 3min at 90.5 °C and a PBS wash, sections were incubated in
blocking solution (10% normal donkey serum, 0.3% Triton X-100,
and 10mg/mL of bovine serum albumin in PBS) for 1 h at RT.
Primary antibody incubation was done overnight at 4 °C with rabbit
anti-ARG-1 (1:50, #93668, Cell Signaling Technology); rabbit anti-
ARG-2 (1:50, #203071, Abcam); mouse anti-NeuN (NeuN) for neurons
(1:500, MAB377, MilliporeSigma), goat anti-Iba1 (Iba1) for microglia
(1:100, NB100-1028, Novus Biologicals), mouse anti-glial fibrillary
acidic protein (GFAP) for astrocytes (1:300, MAB360, MilliporeSigma),
and goat anti-oligodendrocyte transcription factor 2 (Olig2) for
oligodendrocytes (1:50, AF2418, Novus Biologicals). After three 5-
min PBS washes, sections were incubated for 1 h at RT with
appropriate secondary antibodies: donkey anti-goat Alexa Fluor 647
(1:100, A21447, Thermo Fisher), donkey anti-mouse Alexa Fluor 568
(1:100, A10037, Thermo Fisher), and donkey anti-rabbit Alexa Fluor
488 (1:100, A21206, Thermo Fisher). For nuclear staining, sections
were stained with 4′,6-diamino-2-phenylindol for 5min. Slides were
then washed and coverslipped with ProLong Gold antifade (P36930,
Invitrogen). Images were taken with a Leica TCS SP5 Spectral
Confocal Microscope.
Western blotting
Brain tissue was dissected on ice and separated into injured cortex
and hippocampus from ipsilateral (HI) and contralateral (H) sides.
Tissue extracts for Western blot analysis were prepared in RIPA
lysis buffer with added protease and phosphatase inhibitors
(Thermo Fisher Scientific, Waltham, MA). Protein concentration
was determined using the BCA assay (Pierce). Thirty micrograms of
protein was separated by Bis-Tris sodium dodecyl sulfate-
polyacrylamide gel electrophoresis using 12-well gels (Invitrogen,
Carlsbad, CA) and blotted to polyvinylidene difluoride membranes
(Bio-Rad, Hercules, CA) at 30 V overnight at 4 °C. After membrane
incubation in blocking buffer (1× TBS, 5% nonfat dry milk, and
0.1% Tween-20) for 1 h at RT, the membranes were probed with
the following antibodies: rabbit polyclonal anti-ARG-1 antibody
and monoclonal anti-ARG-2 antibody (#9819 ARG-1 polyclonal,
#5503 ARG-2 monoclonal, Cell Signaling Technology, 1:100 in
blocking buffer) and β-actin (A5316 Sigma-Aldrich) overnight at
4 °C. Liver tissue extract was used as an ARG+ control. Mouse
β-actin (Sigma, 1:2000) was used as a loading control. After three
washes in TBST, membranes were incubated with anti-rabbit
immunoglobulin G–horse radish peroxidase conjugate (Cell
Signaling Technology, 1:1000). The signal was visualized with
the ECL chemiluminescence system (Amersham, Little Chalfont,
UK). Optical densities (ODs) were measured on scanned radio-
graphs using Image Studio Lite (Li-Cor Biosciences, version 5.2.5)
and all markers were normalized to β-actin.
ARG assay
Total ARG activity was determined spectrophotometrically (Quan-
tichromTM Arginase Assay kit, BioAssay Systems) as per the
manufacturer’s instructions. Briefly, hippocampal and cortical
tissues were dissected on ice, weighed, and processed in Tris-
HCl with protease and phosphatase inhibitor mixtures (Sigma-
Aldrich) at 10 μL/mg of tissue. Tissue was homogenized with a
Dounce tissue homogenizer and centrifuged at 14,000 r.p.m. for
15min at 4 °C. Supernatant fractions were incubated at 37 °C for
120min with 10mm MnCl2 in ARG buffer to activate the enzyme.
The reaction was stopped by adding urea reagent and samples
were further incubated for 60 min at RT. Samples were analyzed
with a spectrophotometer at 430 nm and ARG activity in
brain samples was calculated as U/L (1 U of ARG converts 1 μmol
of L-arginine to ornithine and urea per minute at pH 9.5 and 37 °C).
Microscopy analysis
To define the anatomical localization of ARG-expressing cells, we
grossly evaluated all areas of brain from rostral to caudal at ×5
magnification. For final analysis we chose the anatomical areas
with ARG+ cells and compared these to the contralateral side and
N (for ARG-1 cortex and striatum, for ARG-2 hippocampus).
Confocal-like Z-stacks (×25 oil objective, 10 μm thick, 1 μm Z step)
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were acquired using a Zeiss microscope equipped with the
confocal-like optigrid device and Volocity software (Improvision).
Analysis was performed in anatomical areas corresponding to
slide 66 of the Allen Mouse Brain Atlas.24 Matching regions of
interest (500 × 400 μm2) in N mice served as a control. Every brain
had a control with no primary antibodies for staining. Image
capturing (using Volocity software) and analysis (Fiji, ImageJ) was
done in a blinded manner. The number of cells that express ARG-1
was quantified manually.
Statistical analysis
Analyses were performed using Prism 7 (GraphPad Software, San
Diego, CA). All data are shown as mean ± SEM. Grouped data were
analyzed using two‐way analysis of variance and subsequently
subjected to Bonferroni t tests for post hoc analyses and
differences were considered significant at p < 0.05. Comparisons
were made between HI, H, and N groups at different timepoints.
For Western blot expression data, t tests were used to compare
expression at P9 vs. P17 only for the N animals to clarify the
significant changes due to neurodevelopment.
RESULTS
Evolution of HI brain injury over time
Brain HI injury evolves over time with corresponding histological
changes at different timepoints ranging from 1 h (P9) to 5 days (P14)
after the injury (Fig. 1). The early changes that occur within 1 h after
the injury are characterized by swelling of cortical neurons seen with
cresyl violet stain (Fig. 1a). At later timepoints, the injury spreads
from the cortex (Fig. 1b, c) into deeper brain structures such as the
hippocampus, thalamus, and striatum (Fig. 1d, e). This pattern
corresponds to lower scores in the more immediate period after the
injury compared to higher scores at the later timepoints (Fig. 1f).
ARG expression changes during neurodevelopment and as a result
of HI
To investigate if ARG expression changes during neurodevelop-
ment and how brain H and HI affect their expression, we
measured the expression of ARG isoforms ARG-1 and ARG-2 in the
cortex and hippocampus at different timepoints after the injury
using Western blotting.
ARG-1 expression
There was a developmental increase in ARG-1 expression from P9
to P17 in both regions of N mice (Fig. 2a, b): cortex at P9 (n= 13)
vs. P17 (n= 17), (Fig. 2a, p < 0.001), hippocampus at P9 (n= 18) vs.
P17 (n= 14), (Fig. 2b, p < 0.0001). Following the Vannucci
procedure, ARG-1 expression increased in the H cortex (n= 7)
5 days after the injury compared both to the HI cortex (n= 7)
(Fig. 2a, p < 0.0001) and age-matched N mice (n= 10), as well as to
the H cortex at all other timepoints (Fig. 2a, p < 0.0001).
Hippocampal expression of ARG-1 was reduced at later timepoints
after the injury compared to N age-matched animals (n= 10–14)
in both H hemisphere (n= 7–11) (3 days, p= 0.0467; 5 days, p=
0.0028; 8 days, p < 0.0001) and HI hemisphere (8 days, p= 0.0003)
(Fig. 2b).
ARG-2 expression
ARG-2 also exhibited a developmental increase in expression from
P9 to P17 in N mice (Fig. 2c, d): cortex at P9 (n= 16) vs. P17 (n= 17)
(Fig. 2c, p < 0.001) and hippocampus at P9 (n= 18) vs. P17 (n= 15)
(Fig. 2d, p < 0.0001). Following the Vannucci procedure, there was a
significant increase in ARG-2 expression in the H cortex at 3 days
(n= 6; p < 0.0001) and 5 days (n= 7; p < 0.0001) after the injury
compared to N age-matched animals (n= 10–16). In HI cortex, ARG-
2 expression peaked at 3 days after the injury (n= 6; p < 0.0001) and
was suppressed by 5 days (n= 7; p < 0.0001). Hippocampal
expression of ARG-2 peaked transiently in H hemisphere 3 days
after the injury (n= 6; p < 0.001 vs. all other timepoints in that
group) and decreased 5 days (n= 7, p < 0.001) and 8 days after the
injury (n= 11; p < 0.001). In the HI hemisphere, there was a
significant increase after HI by 8 days compared to earlier timepoints
from that group (n= 6; p < 0.001 vs. 1 h, 4 h, 12 h, and 1 day).
However, ARG-2 expression was significantly decreased at 8 days in
HI (n= 6; p < 0.0001), as well as in H (n= 11; p < 0.0001) hemisphere
compared to N age-matched animals (n= 14–15, p < 0.0001).
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Fig. 1 Histopathological changes after hypoxic-ischemic brain injury. a–e Histopathological analysis of hypoxic–ischemic brain injury at
different timepoints: cortex at 1 h (a) showing swelling of a few neuronal cells, 4 h (b) with increased area of swollen neurons (arrows),
pyknotic cells (arrowheads), and 5 days (c) after the injury, showing the disruption in cortical structure and cell loss (×10 magnification);
hippocampus after HI at 4 h with no apparent injury (d) and 5 days (e) showing injured area with accumulation of shrunken, pyknotic cells,
and cystic infarction (×4 magnification). f Injury scores after HI at different timepoints: injury extends from the cortex at earlier timepoints to
involvement of deep brain nuclei and adjacent cortex at the later timepoints. ***p < 0.001.
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ARG activity is suppressed by HI
As expression of the enzyme may not necessarily translate to its
function, we measured ARG activity in N mice and after the
Vannucci procedure using a spectrophotometric enzymatic
activity measurement kit. As this kit measures the combined
activity of ARG and does not separate the activity of ARG-1 and 2,
our measures reflected the total ARG activity in the cortex and
hippocampus.
Total ARG activity in the cortex and hippocampus was
constant postnatally from P9 to P14 and did not differ between
the cortex and hippocampus (P9: n= 11 per cortex and
hippocampus group, p= 0.6063, P14: n= 8 per cortex and
hippocampus group; p= 0.2786) (Fig. 3). There was no
significant change in ARG activity in the cortex after the
Vannucci procedure (n= 7–8 per HI and H groups, n= 6–11
per N group; p > 0.05, Fig. 3a). In the hippocampus, however,
there was a significant increase in ARG activity 1 day after the
injury only in H hemisphere (n= 9 per H group and n= 11 per N
group; p= 0.0452, Fig. 3b).
ARG isoforms differ in spatiotemporal expression patterns
Cellular ARG-1 expression. Given the changes in ARG expression
and activity noted, we wanted to clarify the cell types associated
with these changes. Immunofluorescent double-labeling was
performed with ARG-1 and either the neuronal marker NeuN,
microglial marker Iba1, astroglial marker GFAP, or oligodendrocyte
marker Olig2 (Fig. 4a–d). ARG-1 expression was clearly colocalized
only with Iba1+ cells (Fig. 4b).
Anatomically, ARG-1 was colocalized with Iba1+ microglial cells
in the areas of olfactory tubercle, pyriform cortex, pallidum,
striatum, external capsule of corpus callosum, anterior
commissure–temporal limb, amygdala, hypothalamus, and cau-
date (Fig. 5a). Notably, under normal circumstances in N mice,
ARG-1+/Iba1+ cells were absent from the thalamus, hippocampus,
internal capsule, and other parts of fiber tracts or cortex at all
timepoints studied (P9, P10, P14). After HI, ARG-1+ microglia
morphology was clearly transformed to the amoeboid phenotype
at the injury site (Fig. 5b–d) when compared to the ramified
phenotype evident in the N mice (Fig. 5e). The changes in ARG-1+
microglial morphology and accumulation at the injury occurred as
early as 4 h after the injury (Fig. 5f–h). At later timepoints, ARG-1+/
Iba1+ cell numbers remain elevated both at the HI core in the
striatum (24 h: n= 6 per HI and H group, n= 8 per N group;
5 days: n= 6 per HI and H group, n= 14 per N group; 24 h: p <
0.0001 for HI vs. H, p < 0.0001 for HI vs. N; 5 days: p < 0.0001 for HI
vs. H and p < 0.0001 for HI vs. N) and the HI hemisphere (24 h: p=
0.0025 for HI vs. H; p= 0.0002 for HI vs. N; 5 days: p < 0.0001 for HI
vs. H; p < 0.0001 for HI vs. N) (Fig. 5i, j).
Cellular ARG-2 expression. The pattern of ARG-2 expression was
different compared to that of ARG-1. ARG-2 expression was noted
to colocalize largely to NeuN+ cells rather than Iba1+, GFAP+, or
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Fig. 2 Arginase expression in naive mice vs. after brain HI at different timepoints. Protein expression was measured by Western blotting
and presented as the OD ratio to β-actin (for H and HI groups: n= 5 for timepoints 1h, 4h, 12h, n= 9–11 for day 1, n= 6–11 for 3 days, n= 7 for
5 days, n= 6–11 for 8 days after the injury; for N group, n= 5–17 per timepoint). Shown are HI (black), H (gray), and N (white) hemisphere for
ARG-1 in the cortex (a) and hippocampus (b) and ARG-2 in the cortex (c) and hippocampus (d). Brackets show significances as follows: *p <
0.05, **p < 0.01, ***p < 0.001, and #p < 0.0001. For ARG-1, expression at 5 days in H cortex and expression at 8 days in N hippocampus were
both significant against all other timepoints in that group (shown by significance on top of the bar). For ARG-2, expression at 3 days in H and
HI cortex, at 3 days in H hippocampus, and 8 days in HI and N hippocampus were significant against all other timepoints in that group (shown
by significance on top of the bar).
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Olig2+ cells (Fig. 6a–d). Anatomically, ARG-2 expression was
localized in areas of indusium griseum, fasciola cinerea, and CA1
and CA2 of hippocampus, dentate gyrus, and M1 area of the
neocortex (Fig. 6e–j). Following HI, ARG-2-expressing cells
appeared to have an altered morphology consistent with being
injured, in that they appeared pyknotic and shrunken (Fig. 6f, g).
DISCUSSION
In this study, we elucidate, for the first time, alterations that occur
in ARG expression and activity during development from P9 to
P14–P17, as well as after H and HI injury. We found that the
expression of ARG-1 and -2 increases significantly with age in both
the cortex and hippocampus. The expression of ARG-1 and -2 after
injury appear to be intrinsically modulated by H alone or HI. Total
ARG activity is only modulated by H alone. On the cellular level,
both ARG isoforms have very specific expression patterns with
ARG-1 expression predominantly microglial and ARG-2 largely
neuronal, both before and after HI. The highly region- and cell-
specific expression suggests the possibility of specific functions of
ARG isoforms in the brain under physiological and pathological
conditions.
While ARG expression has been described in embryonic and
very early postnatal (E13–P1),16,17 young (4 months) and aged
(24 months) brains in rat,18 to the best of our knowledge this
study is the first to describe isoform-specific ARG expression
patterns during the early postnatal period P9–P17 in mice. We
show that ARG-1 expression increases during normal neurodeve-
lopment from neonatal (P9) to infantile age (P17) and is
predominantly localized to microglia. Our findings are consistent
with Crain et al.,19 who studied ARG-1 expression exclusively in
microglia and detected high messenger RNA expression for the
ARG-1 gene in the early postnatal period (P3) that diminished by
70% at P21 and by 90% at 12 months. Similar to ARG-1, we
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Fig. 4 Cellular expression of ARG-1. Images of double immunofluorescent staining with ARG-1 antibody (green, middle panels) paired with
an antibody specific for neuron (a: NeuN, red panel), microglia (b: Iba1, cyan panel), astrocyte (c: GFAP, red panel), and oligodendrocyte
(d: Olig2, cyan panel). Image ×63 captures region denoted by a box in the third image of that row. Pictured is the injury site of a P10 mouse
exposed to the Vannucci HI model on P9. ARG-1 colocalized with Iba1+ cells (b).
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Fig. 3 Arginase activity in naive mice vs. after brain HI at different timepoints. Arginase activity in cortex (a) and hippocampus (b) in N
mice (white) and in H (gray) and HI hemisphere (black). Unit definition: 1 unit of ARG converts 1 μmol of L-arginine to ornithine and urea per
minute at pH 9.5 and 37 °C. Brackets show significance with *p < 0.05. n= 7–8 per HI and H group and n= 6–11 per N group.
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detected increase in ARG-2 expression from P9 to P17 in neurons.
There is no previous data on ARG-2 expression during P9–P17 in
both the hippocampus and the cortex, and while previous studies
did not detect ARG-2 increase E13–P1,16 they did so in adulthood.20
Currently, it is not possible to correlate isoform-specific
expression to activity as available kits do not differentiate between
ARG-1 and ARG-2. This may be why we failed to detect significant
changes in ARG activity despite an obvious increase in microglial
ARG-1 expression in the cortex. Alternatively, it is possible that
ARG-1+ microglia represent only a small fraction of the expressed
ARG-1. Hippocampal activity however is most likely related to
ARG-2 expression as this is the predominant isoform expressed in
the hippocampus. In our study, ARG activity did not change
significantly during neurodevelopment in either region at the ages
studied (P9, P10, P14), consistent with previous findings.21 The
regional variation in ARG activity across different cortical regions
and subregions of the hippocampus has also been described
previously.22,23 These age-, isoform- and region-specific alterations
in ARG expression and activity highlight the tightly regulated
functions of this enzyme during neurodevelopment.
Both hypoxia and ischemia–reperfusion injury have been
described as a potent stimulus for ARG-1 and ARG-2 expression,25
and consistent with this, we detected a peak in ARG-1 and ARG-2
expression in the H cortex 5 days after the injury, similar to that
reported for ARG-1 by Hamzei et al.26 Current data on the extent
of HI vs. H stimulus on ARG isoform expression are limited and we
speculate that H could be a more potent activator of ARG isoforms
than HI, especially in uninjured regions. However, 8 days after the
injury we see suppression of ARG-1 and ARG-2 expression in the
hippocampus. A similar transient upregulation followed by
suppression of ARG-1 was reported by Quirié et al.27 in an adult
rat photothrombotic stroke model at 15 days after the injury. It is
possible that the variation in timeline of expression between our
studies is related to the age, model, and species studied and
suppression of ARG isoforms may be related to the presence of
endogenous inhibitors. Cellular localization of ARG was isoform
specific, confined to certain anatomical areas, and changed during
development and with injury. Notably, we found ARG-1+microglia
in specific regions of the ventral forebrain and midbrain. A unique
population of ARG-1+ microglia has been shown to represent only
0.5% of microglia formed at E14.5/P4/5, with higher specificity for
females.28 It is possible that ARG-1+ microglia play role in
neurodevelopment and/or sex-specific response to injury.29 ARG-
1+ microglia have been widely reported after HI injury30 and are
thought to mediate neuroprotective effects. While we detected
similarly high numbers of ARG-1+ microglia at the injury site, not
all microglia at the injury site were ARG-1+. This dimorphic
expression could relate to the origin of the microglia or to the
reported microglial “switch” that can happen at the injury site.31
Interestingly, despite significant evident injury in the hippocam-
pus, ARG-1+Iba1+ cells were only minimally present in this area
compared to the injured cortex where ARG-1+Iba1+ were
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Fig. 5 Changes in ARG-1+ microglia after brain HI: a anatomical expression of ARG-1 in mice localizes to pyriform cortex, olfactory tubercle,
pallidum, striatum, external capsule of corpus callosum, anterior commissure–temporal limb, amygdala, hypothalamus, and caudoputamen.
Change in ARG-1+microglia morphology as a result of HI from bushy (b) into amoeboid (c) and round phagocyting (d) phenotype. Changes in
ARG-1+ microglia accumulation in the striatum at different timepoints: N mice (e), and 4 h (f), 1 day (g), and 5 days (h) after injury. ARG-1+
microglia count increases in HI cortex (i) and HI core in the striatum (j) at 1 day after injury, and remains elevated for a prolonged time (n= 5–6
per HI and H group; n= 8 per N group; *p < 0.05, **p < 0.01, #p < 0.0001).
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detectable as early as 4 h after the injury and persisted for 5 days.
This finding demonstrates the heterogeneity of regional responses
to injury processes and confirms that injury, protection and
recovery mechanisms after injury are modulated in a spatiotem-
poral fashion. Despite evidence for ARG-1 expression in astrocytes
along with neurons and microglia after injury,25,26 we failed to
detect colocalization with GFAP. It is possible that differences in
ARG expression and activity during development are based on
species, timing after the injury, and injury type.25,26
ARG-2 belongs to a group of less studied enzymes in the brain
and there are currently few reports on its expression, during
neurodevelopment and particularly after injury, in the developing
brain. Our findings suggest that this isoform may have roles that
are distinct to those of ARG-1, as is evident from the altered
cellular and anatomical expression in the brain. Our study is the
first to describe ARG-2 expression in structures such as the
indusium griseum, fasciola cinerea, or hippocampus. These
structures create a continuum referred to as hippocampal
rudiments.32,33 A few neurons expressing ARG-2 were found also
in the M1 part of the neocortex. Although the exact function of
hippocampal rudiments structures is not well known, they are
believed to play an important role in axonal guidance across the
midline during development of brain commissures and interhemi-
spheric connections.34 The damage of these structures during HI
may lead to a spectrum of neurodevelopmental conditions.35
Expression of ARG-2 in hippocampal rudiments suggests impor-
tant roles for ARG-2 in mediating at least some of these functions.
The presence of ARG-2+ NeuN+ cells in the CA1, CA2 of the
hippocampus also associates this enzyme with processes of
learning and memory formation,36 emotion, neural cell birth,37
among others. While recent reports indicate that acetylcholine,
dopamine, noradrenaline, 5-hydroxytryptamine, and GABA neu-
rons innervate the indusium griseum,38 we speculate ARG-2 to
primarily localize to GABA-ergic neurons considering it plays
important roles in glutamine synthesis.39 After HI, we see
considerable damage of ARG-2+ cells in almost all of these areas,
potentiating a role for ARG-2 in mediating at least some of the
learning, memory, and motor deficits seen after HI,40 and
consequently may present an attractive therapeutic target that
needs to be validated carefully.
In summary, expression and activity of ARG enzymes change
during neurodevelopment and in response to hypoxic and
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Fig. 6 Cellular and anatomical expression of ARG-2. Images of double immunofluorescent staining with ARG-2 antibody (green, middle
panels) paired with an antibody specific for neuron (a: NeuN, red panel), microglia (b: Iba1, cyan panel), astrocyte (c: GFAP, red panel), and
oligodendrocyte (d: Olig2, cyan panel). Image ×63 captures region denoted by a box in the third image of that row. ARG-2 colocalized with
NeuN+ cells (a). Anatomical localization of ARG-2 (e): ARG-2 was found in indusium griseum (f), fasciola cinerea (g), neurons of the neocortex
(h), hippocampus CA1 (i), and CA2 (j). Note the pyknotic cells in the HI hemisphere (arrow); n= 5–6 per H and HI group, n= 8 per N group.
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hypoxic–ischemic brain injury. As ARG-1 localizes mostly to microglia
at the injury site, it is possible that its primary role is mediating
neuroinflammatory processes. ARG-2 expression, on the other hand,
is largely neuronal predominantly in neurodevelopmental structures,
suggesting involvement in developmental processes. Further studies
are needed to elucidate the precise roles of ARG isoforms in
neonatal brain hypoxic and hypoxic–ischemic injury.
ACKNOWLEDGEMENTS
We thank Sandrijn Vanschaik, Jeff Fineman, and Division of Pediatric Critical Care for
their help and support. This work was supported by R35- 5R35NS097299 to D.M.F.,
UCSF Pediatric Critical Care Division, and the Thrasher Research Fund P0530684.
AUTHOR CONTRIBUTIONS
J.K.M.: Substantial contributions to conception and design, data acquisition, analysis,
and interpretation; drafting the article; final approval of the version to be published.
P.P.: Substantial contributions to conception and design, data acquisition, analysis,
and interpretation; drafting the article; final approval of the version to be published.
R.A.S.: Substantial contributions to data acquisition; drafting the article; final approval
of the version to be published. D.M.F.: Substantial contributions to conception and
design, data acquisition, analysis, and interpretation; drafting the article; final
approval of the version to be published.
ADDITIONAL INFORMATION
Competing interests: The material is original, has not been previously published,
and has not been submitted for publication elsewhere while under consideration.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional affiliations.
REFERENCES
1. LaFemina, M. J., Sheldon, R. A. & Ferriero, D. M. Acute hypoxia–ischemia results in
hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr.
Res. 59, 680–683 (2006).
2. Choi, S., Park, C., Ahn, M., Lee, J. H. & Shin, T. Immunohistochemical study of
arginase 1 and 2 in various tissues of rats. Acta Histochem. 114, 487–494 (2012).
3. Handley, R. R. et al. Brain urea increase is an early Huntington’s disease patho-
genic event observed in a prodromal transgenic sheep model and HD cases. Proc.
Natl Acad. Sci. USA 114, E11293–E11302 (2017).
4. Villalba, N. et al. Traumatic brain injury causes endothelial dysfunction in the
systemic microcirculation through arginase-1-dependent uncoupling of endo-
thelial nitric oxide synthase. J. Neurotrauma 34, 192–203 (2017).
5. Ahn, M. et al. Immunohistochemical study of arginase-1 in the spinal cords of
Lewis rats with experimental autoimmune encephalomyelitis. Brain Res. 1453,
77–86 (2012).
6. Petrone, A. B. et al. The role of arginase 1 in post-stroke immunosuppression and
ischemic stroke severity. Transl. Stroke Res. 7, 103–110 (2016).
7. Morris, S. & Wu, G. Arginase: nitric oxide and beyond. Biochem. J. 336, 1–17 (1998).
8. Nguyen, M. C. et al. Arginase inhibition restores peroxynitrite-induced endothelial
dysfunction via L-arginine-dependent endothelial nitric oxide synthase phos-
phorylation. Yonsei Med. J. 57, 1329–1338 (2016).
9. Estévez, A. G. et al. Arginase 1 regulation of nitric oxide production is key to survival
of trophic factor-deprived motor neurons. J. Neurosci. 26, 8512–8516 (2006).
10. Jonathan, D., Cherry, J. D., Olschowka, J. A. & O’Banion, K. M. Neuroinflammation and
M2 microglia: the good, the bad, and the inflamed. J. Neuroinflamm. 11, 98 (2014).
11. Cai, D. et al. Arginase I and polyamines act downstream from cyclic AMP in
overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron 35,
711–719 (2002).
12. Huang, Y., Higginson, D. S., Hester, L., Park, M. H. & Snyder, S. H. Neuronal growth
and survival mediated by eIF5A, a polyamine-modified translation initiation
factor. Proc. Natl Acad. Sci. USA 104, 4194–4199 (2007).
13. Deng, K. et al. Increased synthesis of spermidine as a result of upregulation of
arginase I promotes axonal regeneration in culture and in vivo. J. Neurosci. 29,
9545–9552 (2009).
14. Alizadeh, A. et al. Neuregulin-1 positively modulates glial response and improves
neurological recovery following traumatic spinal cord injury. Glia 65, 1152–1175
(2017).
15. Krystofova, J., Pathipati, P., Russ, J., Sheldon, A. & Ferriero, D. The arginase
pathway in neonatal brain hypoxia–ischemia. Dev. Neurosci. 17, 1–14 (2019).
16. Yu, H. et al. Arginase expression in mouse embryonic development. Mech. Dev.
115, 151–155 (2002).
17. Grillo, M. A., Fossa, T. & Dianzani, U. Arginase, ornithine decarboxylase and
Sadenosylmethionine decarboxylase in chicken brain and retina. Int. J. Biochem.
15, 1081–1084 (1983).
18. Liu, P., Smith, P., Appleton, I., Darlington, C. & Bilkey, D. Age-related changes in
nitric oxide synthase and arginase in the rat prefrontal cortex. Neurobiol. Aging
25, 547–552 (2004).
19. Crain, J. M., Nikodemova, M. & Watters, J. J. Microglia express distinct M1 and M2
phenotypic markers in the postnatal and adult central nervous system in male
and female mice. J. Neurosci. Res. 91, 1143–1151 (2013).
20. Yu, H. et al. Expression of arginase isozymes in mouse brain. J. Neurosci. Res. 66,
406–422 (2001).
21. Konarska, L. & Tomaszewski, L. Studies on L-arginase in developing rat small
instestine, brain, and kidney. I. Ontogenic evolution of arginase lsoenzymes.
Biochem. Med. Metab. Biol. 35, 156–169 (1986).
22. Liu, P., Smith, P. F., Appleton, I., Darlington, C. L. & Bilkey, D. K. Regional variations
and age-related changes in nitric oxide synthase and arginase in the sub-regions
of the hippocampus. Neuroscience 119, 679–687 (2003).
23. Liu, P., Smith, P. F., Appleton, I., Darlington, C. L. & Bilkey, D. K. Nitric oxide
synthase and arginase in the rat hippocampus and the entorhinal, perirhinal,
postrhinal, and temporal cortices: regional variations and age-related changes.
Hippocampus 13, 859–867 (2003).
24. © 2004 Allen Institute for Brain Science. Allen Mouse Brain Atlas https://mouse.
brain-map.org.
25. Shosha, E. et al. Arginase 2 promotes neurovascular degeneration during ische-
mia/reperfusion injury. Cell Death Dis. 7, e2483 (2016).
26. Hamzei Taj, S., Kho, W., Riou, A., Wiedermann, D. & Hoehn, M. MiRNA-124 induces
neuroprotection and functional improvement after focal cerebral ischemia. Bio-
materials 91, 151–165 (2016).
27. Quirié, A. et al. Effect of stroke on arginase expression and localization in the rat
brain. Eur. J. Neurosci. 37, 1193–1202 (2013).
28. Hammond, T. R. et al. Single-cell RNA sequencing of microglia throughout the
mouse lifespan and in the injured brain reveals complex cell-state changes.
Immunity 50, 253–271.e6 (2019).
29. Lee, S. et al. Abstract TP507: sex-related differences in neonatal stroke: Interna-
tional Maternal Newborn Stroke Registry. Stroke 50, ATP507–ATP507 (2019).
30. Hellström Erkenstam, N. et al. Temporal characterization of microglia/macro-
phage phenotypes in a mouse model of neonatal hypoxic–ischemic brain injury.
Front. Cell Neurosci. 10, 286 (2016).
31. Fumagalli, S., Perego, C., Pischiutta, F., Zanier, E. R. & De Simoni, M. G. The
ischemic environment drives microglia and macrophage function. Front. Neurol.
6, 1–19 (2015).
32. Carpenter, M. B. Human Neuroanatomy 7th edn, 532pp (Williams and Wilkins,
Baltimore, 1976).
33. Adamek, G. D., Shipley, M. T. & Sanders, M. S. The indusium griseum in the mouse:
architecture, Timm’s histochemistry and some afferent connections. Brain Res.
Bull. 12, 657–668 (1984).
34. Morcom, L. R., Edwards, T. J., Richards, L. J. Chapter 14—Cortical Architecture,
Midline Guidance, and Tractography of 3D White Matter Tracts. Axons and Brain
Architecture 289–313 (Academic Press, 2016).
35. Paul, L. K. et al. Agenesis of the corpus callosum: genetic, developmental and
functional aspects of connectivity. Nat. Rev. Neurosci. 8, 287–299 (2007).
36. Bendel, O. et al. Reappearance of hippocampal CA1 neurons after ischemia is
associated with recovery of learning and memory. J. Cereb. Blood Flow. Metab. 25,
1586–1595 (2005).
37. Gulyaaeva, N. Functional neurochemistry of the ventral and dorsal hippocampus:
stress, depression, dementia and remote hippocampal damage. Neurochem. Res.
44, 1306–1322 (2019).
38. Di Ieva, A., Fathalla, H., Cusimano, M. D. & Tschabitscher, M. The indusium griseum
and the longitudinal strie of corpus callosum. Cortex 62, 34–40 (2015).
39. Li, H. et al. Regulatory role of arginase I and II in nitric oxide, polyamine,
and proline syntheses in endothelial cells. Am. J. Physiol. Metab. 280, E75–E82
(2001).
40. Martinez-Biarge, M., Ferriero, D. & Cowan, F. M. Perinatal arterial ischemic stroke.
Handb. Clin. Neurol. 162, 239–266 (2019).
Changes in arginase isoforms in a murine model of neonatal brain. . .
JK Mike et al.
8
Pediatric Research _#####################_
